Showing results (131-140 of 140) with videos related to

Sort By:
Pageof 14
You have reached the last page of results.This site can display upto 140 results.
Biochemical and Biophysical Research Communications|November 2, 1999
Structural requirements for Tyr in the consensus sequence Y-E-N of a novel nonphosphorylated inhibitor to the Grb2-SH2 domainY Q Long, Z J Yao, J H Voigt, et al.
International Journal of Oncology|October 17, 1998
NRG-3 in human breast cancers: activation of multiple erbB family proteinsM M Hijazi, P E Young, M K Dougherty, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 1, 1996
Activity of anti-erbB-2 recombinant toxin OLX-209 on lung cancer cell lines in the absence of erbB-2 gene amplificationP G Kasprzyk, T L Sullivan, J D Hunt, et al.
Oncology Nursing Forum|January 1, 1997
Quality of life and the cancer experience: the state-of-the-knowledgeC R King, M Haberman, D L Berry, et al.
Health Technology Assessment (Winchester, England)|November 15, 2013
Improving the economic value of photographic screening for optical coherence tomography-detectable macular oedema: a prospective, multicentre, UK studyJ Olson, P Sharp, K Goatman, et al.
Journal of Thrombosis and Haemostasis : JTH|October 31, 2009
Ability of VKORC1 and CYP2C9 to predict therapeutic warfarin dose during the initial weeks of therapyN S Ferder, C S Eby, E Deych, et al.
Journal of the National Cancer Institute|October 6, 2000
Immunoconjugates of geldanamycin and anti-HER2 monoclonal antibodies: antiproliferative activity on human breast carcinoma cell linesR Mandler, C Wu, E A Sausville, et al.
Cancer Gene Therapy|November 1, 2008
Translational strategies exploiting TNF-alpha that sensitize tumors to radiation therapyH J Mauceri, M A Beckett, H Liang, et al.
Clinical Pharmacology and Therapeutics|March 5, 2010
A polymorphism in the VKORC1 regulator calumenin predicts higher warfarin dose requirements in African AmericansD Voora, D C Koboldt, C R King, et al.
Journal of Thrombosis and Haemostasis : JTH|July 30, 2008
Laboratory and clinical outcomes of pharmacogenetic vs. clinical protocols for warfarin initiation in orthopedic patientsP A Lenzini, G R Grice, P E Milligan, et al.
Pageof 14